Half of the patients who received an experimental vaccine for pancreas cancer being developed by Roche and BioNTech following ...
BioNTech's malaria vaccine trial faces an FDA clinical hold. The company is addressing concerns and collaborating with ...
The FDA has placed a hold on BioNTech’s phase 1/2a trial, pausing the company’s efforts to develop a RNA-based vaccine for ...
The vaccine space has been battered by strong headwinds in recent weeks, including high-level disruptions to FDA and CDC ...
BioNTech SE (NASDAQ:BNTX) said on Tuesday, that the U.S. Food and Drug Administration informed of a clinical hold on the ...
BioNTech's early-to-mid stage trial of an experimental malaria vaccine has been put on a clinical hold by the U.S. Food and ...
The FDA’s clinical hold has prompted a cautious response from investors, reflecting the heightened regulatory scrutiny that BioNTech now faces. The company’s immediate focus will be on resolving the ...
In a regulatory filing, BioNTech (BNTX) disclosed that the U.S. Food and Drug Administration has informed BioNTech SE that it has placed a ...
We recently published a list of the 10 Best Vaccine Stocks to Buy According to Hedge Funds. In this article, we are going to ...
ThePrint on MSN1d
A personalised vaccine for pancreatic cancer brings ‘hope where none existed before’Researchers associated with the New York-based Memorial Sloan Kettering Cancer Center have obtained positive results in the ...
US health officials are reevaluating a $590 million contract for bird flu shots that the Biden administration awarded to ...
In a small trial, nearly half of pancreatic cancer patients who received an mRNA vaccine for the disease had no relapse three ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback